Bentham Science Logo

Track Your Manuscript:


Clinical Cancer Drugs

Volume 7, 2 Issues, 2020
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Clinical Cancer Drugs, Volume 7 - Number 2


Editorial   Open Access





Review Article (Mini-Review)

Does the Oxazolidinone Derivatives Constitute a Functional Approach for Cancer Therapy?

, 7(2): 95 - 106

Eduardo Augusto Vasconcelos de Freitas Ramalho*, Marina Galdino da Rocha Pitta, Hernando de Barros Siqueira Neto and Ivan da Rocha Pitta


DOI: 10.2174/2212697X07999200807210936



Research Article

Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice

, 7(2): 113 - 118

Vadim S. Pokrovsky*, Vladimir A. Zolottsev, Alexandra S. Latysheva, Vasiliy A. Kudinov, Natalia Yu Anisimova, R.L.M. Almanza, Olga Yu Alekseeva, Konstantin K. Baskaev, Galina B. Smirnova, Yulia A. Borisova and Olga M. Ipatova


DOI: 10.2174/2212697X07999200511082225



Clinical Trial   Open Access

A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies

, 7(2): 125 - 132

Karen A. Gelmon*, Christian Kollmannsberger, Stephen Chia, Anna V. Tinker, Teresa Mitchell, Stephen Lam, Teresa Joshi, David Kwok, John Ostrem, Simon Sutcliffe and Daniel J. Renouf


DOI: 10.2174/1574893615999200601130946



Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Biography
View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.

Advertisement

How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog